Member Highlights
Member Highlights Interview with Signals+ Co-Editor-in-Chief Daniella Schwartz
I like to think of myself as bivalent – kind of like the COVID vaccine. A big chunk of my lab’s work focuses on the regulation of IL-9 and the functions of IL-9 in the context of autoimmune and autoinflammatory (rheumatic) diseases. But I also have a growing program studying the genetic architecture of autoimmune and autoinflammatory conditions, based on rare/monogenic variants. This includes managing one of the only coordinated adult-pediatric autoinflammatory diagnosis/treatment programs in the US. [READ MORE]